Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Higher doses of 5α-reductase inhibitors may lower mortality risk, but low doses increase it.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

5ARIs lower PSA levels, but other tests are needed to avoid missing aggressive prostate cancer.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Axitinib treatment turned a man's grey hair back to black.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

5 Alpha-Reductase Inhibitors reduce the effects of testosterone by blocking its conversion into a stronger form.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

5-Alpha-Reductase Inhibitors can cause negative side effects.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.